SB 1501, the Safe American Food Exports Act of 2025, would amend the Animal Health Protection Act to help reduce the trade consequences of animal disease outbreaks. The bill directs the Secretary of Agriculture, through APHIS, USDA trade officials, and FSIS, to consult with the U.S. Trade Representative and may negotiate with foreign governments on regionalization, zoning, compartmentalization, and related arrangements for outbreaks of animal diseases that affect trade. The goal is to preserve access to export markets for U.S. livestock and animal products when disease outbreaks occur.
The bill also states that these negotiations should take into account accepted global research advances. At the same time, it includes a rule of construction making clear that the measure does not limit the U.S. Trade Representative’s authority to negotiate trade agreements and does not require other trade deals to include these animal-disease-related provisions. In practical terms, the bill would add an explicit federal policy tool for managing animal-health trade disruptions without changing the broader structure of U.S. trade negotiation authority.
Impact
The bill would amend 7 U.S.C. 8304 in the Animal Health Protection Act by adding a new subsection authorizing federal officials to pursue export-market arrangements tied to animal disease outbreaks. It would affect USDA agencies involved in animal health, food inspection, and trade policy, as well as foreign trading partners that import U.S. livestock and animal products. The measure is designed to support continuity of agricultural exports during disease events, potentially reducing market closures or trade bans through negotiated regionalization or zoning agreements.
Sentiment
Based on the bill text and the limited procedural history, the measure appears to have a generally pro-agriculture, pro-trade orientation with no recorded opposition in the available materials. The bipartisan sponsorship suggests support across party lines for protecting U.S. livestock exporters and improving disease-response trade tools. No committee debate or votes are available in the provided record, so there is no evidence of formal controversy at this stage.
Contention
The main policy issue is whether the federal government should proactively negotiate disease-related trade arrangements with foreign governments and how far those arrangements should go. Potential points of concern could include the practical enforceability of regionalization or zoning agreements, the extent to which scientific research should influence negotiations, and whether such provisions could complicate broader trade talks. The bill addresses one possible objection directly by clarifying that it does not constrain U.S. Trade Representative authority or require these provisions in other trade agreements.
Expanded Food Safety Investigation Act of 2025This bill provides that the Food and Drug Administration (FDA) may, under specified circumstances, request access to a concentrated animal-feeding operation (i.e., a stabled or confined animal-feeding operation of a specified size) to conduct microbial sampling.Specifically, the bill allows the FDA to request access if the FDA determines that sampling is necessary to facilitate an investigation of a foodborne-illness outbreak, determine the cause of an outbreak, or address other public health needs. Concentrated animal-feeding operations must provide reasonable access for sampling, including sampling of plants, animals, water, and the environment. The bill imposes penalties on operations that refuse to provide reasonable access. Data collected in sampling efforts under this bill must be shared with the Department of Agriculture and state and federal public health agencies to facilitate the detection, investigation, and prevention of foodborne illness.